Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Drug Discovery Today|August 4, 2010
Medicines discovery in the 21st century: the case for a stakeholder corporationJohn Dixon, Paul England, Geoff Lawton, et al.Analytical Biochemistry|April 2, 2016
Surface plasmon resonance biosensor assay for the analysis of small-molecule inhibitor binding to human and parasitic phosphodiesterasesMarco Siderius, Anitha Shanmugham, Paul England, et al.Antimicrobial Agents and Chemotherapy|November 6, 2013
Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotesErika van den Bogaart, Gerard J Schoone, Paul England, et al.Journal of Biomolecular Screening|September 19, 2014
Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hitsAntoni R Blaazer, Kristina M Orrling, Anitha Shanmugham, et al.Journal of Medicinal Chemistry|September 12, 2012
Catechol pyrazolinones as trypanocidals: fragment-based design, synthesis, and pharmacological evaluation of nanomolar inhibitors of trypanosomal phosphodiesterase B1Kristina M Orrling, Chimed Jansen, Xuan Lan Vu, et al.Pageof 1